Data di Pubblicazione:
2019
Citazione:
Lipid-based vectors for therapeutic mrna-based anti-cancer vaccines / M.L. Guevara, S. Persano, F. Persano. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1381-6128. - 25:13(2019), pp. 1443-1454. [10.2174/1381612825666190619150221]
Abstract:
Cancer vaccines have been widely explored as a key tool for effective cancer immunotherapy. Despite a convincing rationale behind cancer vaccines, extensive past efforts were unsuccessful in mediating significantly relevant anti-tumor activity in clinical studies. One of the major reasons for such poor outcome, among others, is the low immunogenicity of more traditional vaccines, such as peptide-, protein-and DNA-based vaccines. Recently, mRNA emerged as a promising alternative to traditional vaccine strategies due to its high immunogenicity, suitability for large-scale and low-cost production, and superior safety profile. However, the clinical application of mRNA-based anti-cancer vaccines has been limited by their instability and inefficient in vivo delivery. Recent technological advances have now largely overcome these issues and lipid-based vectors have demonstrated encouraging results as mRNA vaccine platforms against several types of cancers. This review intends to provide a detailed overview of lipid-based vectors for the development of therapeutic mRNA-based anti-tumor vaccines.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
cancer; immunotherapy; liposome; MRNA; nanoparticles; non-viral vectors; vaccines
Elenco autori:
M.L. Guevara, S. Persano, F. Persano
Link alla scheda completa: